Jelmyto

Product manufactured by Urogen Pharma, Inc.

Application Nr Approved Date Route Status External Links
NDA211728 None None None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Jelmyto™ Is Indicated For The Treatment Of Adult Patients With Low-Grade Upper Tract Urothelial Cancer (Lg-Utuc). Jelmyto Is An Alkylating Drug Indicated For The Treatment Of Adult Patients With Low-Grade Upper Tract Urothelial Cancer (Lg-Utuc). ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Mitomycin MITOMYCIN ZINC30726187

Comments